195 related articles for article (PubMed ID: 1365860)
1. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
Aulakh CS; Hill JL; Yoney HT; Murphy DL
Psychopharmacology (Berl); 1992; 109(4):444-8. PubMed ID: 1365860
[TBL] [Abstract][Full Text] [Related]
2. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors.
Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Murphy DL
Psychopharmacology (Berl); 1996 Feb; 123(4):333-9. PubMed ID: 8867872
[TBL] [Abstract][Full Text] [Related]
3. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors.
Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Hill JL; Murphy DL
Psychopharmacology (Berl); 1995 Jan; 117(2):193-9. PubMed ID: 7753967
[TBL] [Abstract][Full Text] [Related]
4. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
[TBL] [Abstract][Full Text] [Related]
5. Functional subsensitivity of 5-hydroxytryptamine1C or alpha 2 adrenergic heteroreceptors mediating clonidine-induced growth hormone release in the Fawn-Hooded rat strain relative to the Wistar rat strain.
Aulakh CS; Hill JL; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1992 Sep; 262(3):1038-43. PubMed ID: 1356149
[TBL] [Abstract][Full Text] [Related]
6. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
Lawton CL; Blundell JE
Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
[TBL] [Abstract][Full Text] [Related]
7. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
Edwards E; Ashby CR; Wang RY
Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
[TBL] [Abstract][Full Text] [Related]
8. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
Aulakh CS; Mazzola-Pomietto P; Wozniak KM; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1994 Jul; 270(1):127-32. PubMed ID: 8035308
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
Bagdy G; Kalogeras KT
Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
[TBL] [Abstract][Full Text] [Related]
10. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
11. Modulation of brainstem 5-HT1C receptors by serotonergic drugs in the rat.
Pranzatelli MR; Tailor PT
Gen Pharmacol; 1994 Oct; 25(6):1279-84. PubMed ID: 7875557
[TBL] [Abstract][Full Text] [Related]
12. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Albinsson A; Palazidou E; Stephenson J; Andersson G
Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
[TBL] [Abstract][Full Text] [Related]
14. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
Kłodzińska A; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
[TBL] [Abstract][Full Text] [Related]
15. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
Chaouloff F; Laude D; Baudrie V
Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
Berendsen HH; Broekkamp CL
Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
18. Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI).
Pranzatelli MR
Neurosci Lett; 1990 Jul; 115(1):74-80. PubMed ID: 2216059
[TBL] [Abstract][Full Text] [Related]
19. Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists.
Pranzatelli MR; Murthy JN; Tailor PT
Eur J Pharmacol; 1993 Jan; 244(1):1-5. PubMed ID: 8420788
[TBL] [Abstract][Full Text] [Related]
20. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Done CJ; Sharp T
Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
